Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Kimberly Jordan

Concepts (288)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Tumor Microenvironment
11
2024
627
1.300
 Why?
Ovarian Neoplasms
6
2024
482
1.200
 Why?
T-Lymphocytes
11
2022
1937
1.200
 Why?
Cancer Vaccines
7
2021
164
1.190
 Why?
Myeloid-Derived Suppressor Cells
5
2023
64
1.120
 Why?
Antigens, Neoplasm
6
2021
308
0.740
 Why?
Focal Adhesion Protein-Tyrosine Kinases
1
2020
35
0.700
 Why?
Antineoplastic Combined Chemotherapy Protocols
5
2024
1560
0.690
 Why?
Receptors, Antigen, T-Cell
7
2021
707
0.690
 Why?
Cytoreduction Surgical Procedures
1
2020
59
0.670
 Why?
Baculoviridae
3
2009
44
0.660
 Why?
Chemotherapy, Adjuvant
1
2020
377
0.630
 Why?
Image Processing, Computer-Assisted
1
2023
739
0.620
 Why?
Neoadjuvant Therapy
2
2022
379
0.610
 Why?
Insecta
3
2009
63
0.600
 Why?
Extracellular Vesicles
1
2020
129
0.600
 Why?
Granulocytes
1
2017
77
0.530
 Why?
Melanoma
4
2023
730
0.530
 Why?
Pancreatic Cyst
1
2017
52
0.510
 Why?
Lymphocyte Activation
4
2017
1110
0.510
 Why?
Monocytes
2
2020
554
0.470
 Why?
CD8-Positive T-Lymphocytes
7
2024
855
0.460
 Why?
Spleen
1
2017
508
0.460
 Why?
Neoplasms
6
2017
2454
0.460
 Why?
Vaccines
2
2010
400
0.450
 Why?
Programmed Cell Death 1 Receptor
3
2022
232
0.450
 Why?
Tomography, X-Ray Computed
1
2023
2511
0.430
 Why?
Myeloid Cells
2
2020
142
0.430
 Why?
Colorectal Neoplasms
3
2024
748
0.420
 Why?
Vaccines, Subunit
2
2012
48
0.420
 Why?
Complementarity Determining Regions
1
2012
49
0.380
 Why?
Benzimidazoles
2
2024
162
0.350
 Why?
Gamma Rays
2
2021
54
0.340
 Why?
Antineoplastic Agents, Immunological
4
2020
181
0.330
 Why?
Inflammation
1
2020
2748
0.320
 Why?
Cell Line, Tumor
8
2024
3185
0.310
 Why?
Xenograft Model Antitumor Assays
5
2024
808
0.310
 Why?
Breast Neoplasms
1
2020
2104
0.300
 Why?
Pancreatic Neoplasms
3
2021
879
0.290
 Why?
Mice
20
2024
16983
0.290
 Why?
Mice, Inbred BALB C
8
2021
1248
0.280
 Why?
H-2 Antigens
1
2008
115
0.280
 Why?
Carcinoma, Pancreatic Ductal
2
2021
269
0.280
 Why?
Proteome
2
2022
440
0.270
 Why?
Antigens
1
2009
356
0.270
 Why?
Antibodies, Monoclonal, Humanized
2
2024
756
0.270
 Why?
Peptides
4
2021
926
0.270
 Why?
Tumor Escape
2
2017
39
0.260
 Why?
Peptide Library
4
2013
84
0.260
 Why?
Survival Analysis
4
2021
1271
0.260
 Why?
Vaccination
3
2010
1348
0.260
 Why?
Female
26
2024
68829
0.250
 Why?
Lung Neoplasms
3
2024
2344
0.240
 Why?
Transcriptome
2
2022
875
0.240
 Why?
Cell Proliferation
6
2024
2378
0.240
 Why?
Models, Biological
2
2021
1724
0.230
 Why?
Lymphocytes, Tumor-Infiltrating
3
2021
204
0.230
 Why?
Major Histocompatibility Complex
4
2021
229
0.230
 Why?
Humans
40
2024
129847
0.220
 Why?
Tryptophan Oxygenase
1
2024
34
0.220
 Why?
Keratins
1
2024
175
0.220
 Why?
Bevacizumab
1
2024
128
0.220
 Why?
Cystadenocarcinoma, Serous
1
2024
68
0.220
 Why?
Animals
23
2024
35409
0.220
 Why?
Interferons
2
2022
189
0.210
 Why?
Signal-To-Noise Ratio
1
2023
68
0.210
 Why?
Prognosis
5
2024
3773
0.210
 Why?
Neoplasms, Experimental
2
2021
171
0.210
 Why?
Carcinoma, Non-Small-Cell Lung
2
2022
1050
0.210
 Why?
Small Cell Lung Carcinoma
1
2024
88
0.210
 Why?
Histone-Lysine N-Methyltransferase
1
2024
124
0.200
 Why?
Artifacts
1
2023
127
0.200
 Why?
Disease Models, Animal
4
2024
4077
0.200
 Why?
Dendritic Cells
4
2020
481
0.200
 Why?
Fallopian Tubes
1
2022
30
0.200
 Why?
Ephrin-B2
2
2021
50
0.200
 Why?
Fibrosis
2
2024
526
0.190
 Why?
Tretinoin
2
2023
121
0.190
 Why?
Neoplasms, Second Primary
1
2023
106
0.190
 Why?
Flow Cytometry
5
2022
1160
0.190
 Why?
Blood
1
2022
105
0.190
 Why?
Synovial Membrane
1
2022
91
0.180
 Why?
Gene Expression Profiling
3
2021
1686
0.180
 Why?
Mycosis Fungoides
1
2021
61
0.180
 Why?
Ovary
1
2022
209
0.180
 Why?
Middle Aged
11
2024
31177
0.180
 Why?
ADAM10 Protein
1
2021
30
0.180
 Why?
Seroconversion
1
2021
46
0.180
 Why?
Proteomics
3
2024
1058
0.170
 Why?
Amyloid Precursor Protein Secretases
1
2021
80
0.170
 Why?
Oligonucleotides, Antisense
1
2020
112
0.170
 Why?
Databases, Genetic
1
2021
228
0.170
 Why?
Eosinophilic Esophagitis
1
2024
318
0.170
 Why?
Immunity
1
2020
138
0.160
 Why?
Macrophages
2
2024
1489
0.160
 Why?
Splenectomy
1
2020
58
0.160
 Why?
Radiation Injuries
1
2021
135
0.160
 Why?
Radiosurgery
1
2022
321
0.160
 Why?
Diagnostic Imaging
1
2022
326
0.160
 Why?
Case-Control Studies
3
2022
3384
0.160
 Why?
Immunotherapy
4
2020
596
0.160
 Why?
Survival Rate
2
2021
1872
0.160
 Why?
Cell Adhesion
1
2020
455
0.160
 Why?
Neoplasm Invasiveness
1
2020
484
0.150
 Why?
Papillomavirus Infections
1
2022
297
0.150
 Why?
Adrenal Cortex Neoplasms
1
2020
60
0.150
 Why?
Epithelial-Mesenchymal Transition
1
2021
201
0.150
 Why?
Receptor, EphB4
1
2019
36
0.150
 Why?
Adrenocortical Carcinoma
1
2020
63
0.150
 Why?
STAT3 Transcription Factor
1
2020
194
0.150
 Why?
Cell Communication
1
2020
301
0.150
 Why?
T-Lymphocytes, Regulatory
3
2020
373
0.150
 Why?
Isoxazoles
1
2018
54
0.150
 Why?
Ipilimumab
1
2018
31
0.150
 Why?
Biomarkers, Tumor
2
2022
1161
0.150
 Why?
Interferon-alpha
1
2019
194
0.150
 Why?
Multiple Sclerosis
1
2024
438
0.150
 Why?
Autoantigens
1
2021
420
0.150
 Why?
Metabolome
1
2021
339
0.140
 Why?
Mice, Transgenic
3
2024
2135
0.140
 Why?
Immunophenotyping
3
2017
310
0.140
 Why?
Lymphoma, Non-Hodgkin
1
2018
79
0.140
 Why?
Antigens, CD19
1
2018
120
0.140
 Why?
Colonic Neoplasms
2
2012
241
0.140
 Why?
Drug Discovery
1
2018
131
0.140
 Why?
Head and Neck Neoplasms
1
2022
544
0.140
 Why?
Combined Modality Therapy
1
2020
1201
0.140
 Why?
Histone Deacetylase Inhibitors
1
2019
209
0.140
 Why?
Multiple Myeloma
1
2018
125
0.130
 Why?
Oxidation-Reduction
1
2020
1031
0.130
 Why?
Adult
8
2024
35634
0.130
 Why?
Problem-Based Learning
1
2017
82
0.130
 Why?
Adipose Tissue
1
2020
594
0.130
 Why?
Spodoptera
2
2021
37
0.130
 Why?
Students, Pharmacy
1
2017
96
0.130
 Why?
Cell Count
1
2017
318
0.130
 Why?
Triple Negative Breast Neoplasms
1
2019
193
0.130
 Why?
Algorithms
1
2023
1617
0.120
 Why?
Signal Transduction
4
2024
4935
0.120
 Why?
Cytotoxicity, Immunologic
2
2020
220
0.120
 Why?
Immunotherapy, Adoptive
1
2018
300
0.120
 Why?
Liver Neoplasms
1
2020
636
0.120
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2018
279
0.120
 Why?
Perception
1
2017
347
0.120
 Why?
Aged
6
2024
22107
0.110
 Why?
Membrane Proteins
1
2021
1119
0.110
 Why?
Tumor Cells, Cultured
3
2021
931
0.110
 Why?
Skin Neoplasms
1
2021
830
0.110
 Why?
Mice, Nude
3
2020
680
0.110
 Why?
Blood Cell Count
1
2013
53
0.110
 Why?
Young Adult
3
2021
12467
0.100
 Why?
Arthritis, Rheumatoid
1
2022
1098
0.100
 Why?
Prostatic Neoplasms
1
2020
999
0.100
 Why?
Down Syndrome
1
2019
478
0.100
 Why?
Lipopolysaccharide Receptors
1
2013
86
0.100
 Why?
Interferon-gamma
2
2021
773
0.100
 Why?
Immunohistochemistry
3
2022
1690
0.100
 Why?
Male
11
2024
63759
0.100
 Why?
Apoptosis
4
2024
2489
0.100
 Why?
Disease Progression
2
2024
2628
0.090
 Why?
Suppressor Factors, Immunologic
1
2011
4
0.090
 Why?
Epitopes, T-Lymphocyte
1
2012
186
0.090
 Why?
Cells, Cultured
2
2017
4102
0.090
 Why?
Datasets as Topic
2
2022
109
0.090
 Why?
B7-H1 Antigen
2
2024
198
0.090
 Why?
Follow-Up Studies
1
2020
4896
0.090
 Why?
Curriculum
1
2017
928
0.090
 Why?
Transcription Factors
1
2018
1645
0.090
 Why?
Neoplasm Proteins
1
2013
417
0.090
 Why?
Immunodominant Epitopes
1
2010
28
0.080
 Why?
Biomarkers
4
2024
3971
0.080
 Why?
Neoplasm Staging
1
2013
1282
0.080
 Why?
Drug Resistance, Neoplasm
2
2024
753
0.080
 Why?
Genes, MHC Class I
1
2009
34
0.080
 Why?
Complement System Proteins
2
2022
319
0.070
 Why?
Genetic Engineering
1
2009
87
0.070
 Why?
Histocompatibility Antigens Class I
1
2010
200
0.070
 Why?
Cell Survival
2
2024
1086
0.070
 Why?
Histocompatibility Antigen H-2D
1
2008
21
0.070
 Why?
Cross-Priming
1
2008
18
0.070
 Why?
CD11c Antigen
1
2008
41
0.070
 Why?
Adjuvants, Immunologic
1
2009
222
0.070
 Why?
RNA, Messenger
3
2024
2703
0.070
 Why?
Molecular Targeted Therapy
2
2020
391
0.070
 Why?
Cell Culture Techniques
1
2009
349
0.070
 Why?
Aged, 80 and over
2
2020
7066
0.070
 Why?
Immune Tolerance
1
2008
356
0.060
 Why?
Gene Expression
2
2022
1465
0.060
 Why?
Ligands
2
2022
621
0.060
 Why?
Cancer-Associated Fibroblasts
1
2024
13
0.060
 Why?
Cell Line
1
2010
2780
0.060
 Why?
Neuroendocrine Cells
1
2024
31
0.060
 Why?
Histocompatibility Antigens
1
2024
107
0.050
 Why?
Cell Differentiation
1
2011
1900
0.050
 Why?
Neoplasm Grading
1
2024
283
0.050
 Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2024
90
0.050
 Why?
Microsatellite Repeats
1
2024
163
0.050
 Why?
Kynurenine
1
2024
113
0.050
 Why?
Neuroendocrine Tumors
1
2024
99
0.050
 Why?
Imidazoles
1
2024
235
0.050
 Why?
Mice, Inbred C57BL
3
2021
5468
0.050
 Why?
Tryptophan
1
2024
177
0.050
 Why?
Adolescent
1
2020
20451
0.050
 Why?
Sf9 Cells
1
2021
9
0.050
 Why?
CD47 Antigen
1
2021
28
0.050
 Why?
Tissue Distribution
1
2022
316
0.050
 Why?
Autophagy
1
2024
266
0.050
 Why?
Lymphocytes
2
2020
377
0.050
 Why?
Hypoalbuminemia
1
2021
30
0.040
 Why?
Access to Information
1
2021
47
0.040
 Why?
Carcinogenesis
1
2022
214
0.040
 Why?
Ranolazine
1
2020
25
0.040
 Why?
Animals, Genetically Modified
1
2002
231
0.040
 Why?
Cluster Analysis
1
2022
483
0.040
 Why?
Seroepidemiologic Studies
1
2021
157
0.040
 Why?
Enzyme Inhibitors
1
2024
827
0.040
 Why?
Data Mining
1
2021
110
0.040
 Why?
RNA, Viral
1
2024
620
0.040
 Why?
Receptors, CCR
1
2020
8
0.040
 Why?
Cytokines
3
2018
2022
0.040
 Why?
Interleukin-6
1
2024
724
0.040
 Why?
Platelet Count
1
2020
82
0.040
 Why?
Hematopoiesis
1
2021
184
0.040
 Why?
Basophils
1
2020
73
0.040
 Why?
Lymphocyte Subsets
1
2020
84
0.040
 Why?
Tumor Burden
1
2020
287
0.040
 Why?
Mutation
1
2010
3706
0.040
 Why?
Swine
1
2002
761
0.040
 Why?
Leukocyte Count
1
2020
326
0.040
 Why?
Postoperative Period
1
2020
330
0.040
 Why?
Pancreaticoduodenectomy
1
2020
158
0.040
 Why?
Biological Availability
1
2018
147
0.040
 Why?
Immunoglobulin G
1
2003
851
0.040
 Why?
Automation
1
2018
81
0.040
 Why?
Killer Cells, Natural
1
2021
426
0.040
 Why?
Radiotherapy
1
2019
185
0.040
 Why?
Gene Knockdown Techniques
1
2019
317
0.040
 Why?
Complement Activation
1
2021
385
0.040
 Why?
Aging
1
2008
1774
0.040
 Why?
Inpatients
1
2022
477
0.040
 Why?
Structure-Activity Relationship
1
2018
549
0.030
 Why?
Lipid Metabolism
1
2020
503
0.030
 Why?
B-Lymphocytes
1
2003
816
0.030
 Why?
Drug Delivery Systems
1
2020
337
0.030
 Why?
Molecular Structure
1
2018
483
0.030
 Why?
Homeostasis
1
2021
605
0.030
 Why?
Protein Domains
1
2018
254
0.030
 Why?
Administration, Oral
1
2018
787
0.030
 Why?
Cell Movement
1
2021
950
0.030
 Why?
Comorbidity
1
2021
1551
0.030
 Why?
Metabolomics
1
2021
652
0.030
 Why?
Education, Pharmacy
1
2017
119
0.030
 Why?
Educational Measurement
1
2017
264
0.030
 Why?
Dose-Response Relationship, Drug
1
2018
2016
0.030
 Why?
Severity of Illness Index
1
2022
2739
0.030
 Why?
Neutrophils
1
2019
1209
0.030
 Why?
Program Evaluation
1
2017
878
0.030
 Why?
Antineoplastic Agents
1
2024
2045
0.030
 Why?
Cross Reactions
1
2012
133
0.020
 Why?
Indoleamine-Pyrrole 2,3,-Dioxygenase
1
2011
55
0.020
 Why?
Hospitalization
1
2021
2079
0.020
 Why?
Culture Media, Conditioned
1
2011
110
0.020
 Why?
Endocytosis
1
2011
162
0.020
 Why?
Universities
1
2013
409
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2012
836
0.020
 Why?
Treatment Outcome
1
2024
10241
0.020
 Why?
In Vitro Techniques
1
2011
1092
0.020
 Why?
Enterotoxins
1
2006
87
0.020
 Why?
T-Lymphocytes, Cytotoxic
1
2006
170
0.020
 Why?
Drug Design
1
2006
158
0.020
 Why?
DNA Primers
1
2006
508
0.020
 Why?
Antigen Presentation
1
2006
207
0.010
 Why?
Blood Cells
1
2003
38
0.010
 Why?
Colorado
1
2013
4410
0.010
 Why?
CD40 Ligand
1
2003
38
0.010
 Why?
Retrospective Studies
1
2020
14553
0.010
 Why?
Coculture Techniques
1
2003
224
0.010
 Why?
Amino Acid Sequence
1
2006
2057
0.010
 Why?
Molecular Sequence Data
1
2006
2833
0.010
 Why?
Antibody Formation
1
2003
291
0.010
 Why?
Immunoglobulins
1
2002
162
0.010
 Why?
Mice, Knockout
1
2008
2888
0.010
 Why?
Organ Size
1
2002
456
0.010
 Why?
Cattle
1
2003
978
0.010
 Why?
Echocardiography
1
2002
636
0.010
 Why?
Birth Weight
1
2002
505
0.010
 Why?
Placenta
1
2002
716
0.010
 Why?
Phenotype
1
2002
3062
0.010
 Why?
Jordan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (288) concept(s)
_
Co-Authors Expand Description
See all (136) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)